• Explore /
  • Poster
  • / Impact of age on safety and efficacy of first-line FOLFOXIRI/bevacizumab in mCRC: A pooled analysis of TRIBE and TRIBE2 studies.

Impact of age on safety and efficacy of first-line FOLFOXIRI/bevacizumab in mCRC: A pooled analysis of TRIBE and TRIBE2 studies.

Abstract Poster

Authors

null

Federica Marmorino

Department of Translational Research and New Technologies in Medicine and Surgery, Unit of Medical Oncology 2, Azienda Ospedaliera Universitaria Pisana, Pisa, Italy

Federica Marmorino , Daniele Rossini , Giuseppe Aprile , Mariaelena Casagrande , Sara Lonardi , Sabina Murgioni , Emanuela Dell'Aquila , Gianluca Tomasello , Carlotta Antoniotti , Beatrice Borelli , Gemma Zucchelli , Federica Urbano , Monica Ronzoni , Alberto Zaniboni , Sara Manglaviti , Angela Buonadonna , Giuliana Ritorto , Giacomo Allegrini , Alfredo Falcone , Chiara Cremolini

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2019 ASCO Annual Meeting

Session Type

Poster Session

Session Title

Gastrointestinal (Colorectal) Cancer

Track

Gastrointestinal Cancer—Colorectal and Anal

Sub Track

Colorectal Cancer–Advanced Disease

Citation

J Clin Oncol 37, 2019 (suppl; abstr 3536)

DOI

10.1200/JCO.2019.37.15_suppl.3536

Abstract #

3536

Poster Bd #

28

Abstract Disclosures

Similar Posters

First Author: Hironaga Satake

First Author: Sebastian Stintzing

First Author: Sebastian Stintzing

First Author: Akihito Tsuji